4104 — Excelsior Medical Co Balance Sheet
0.000.00%
- TWD13.89bn
- TWD14.92bn
- TWD8.54bn
- 69
- 54
- 92
- 86
Annual balance sheet for Excelsior Medical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,555 | 3,772 | 3,229 | 3,406 | 5,048 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,940 | 4,475 | 5,029 | 5,815 | 5,607 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,502 | 9,308 | 9,528 | 10,692 | 12,221 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 834 | 914 | 1,028 | 1,071 | 1,121 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 14,005 | 15,105 | 16,483 | 18,080 | 20,368 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,020 | 4,955 | 5,752 | 6,679 | 8,289 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,414 | 7,367 | 8,282 | 9,467 | 11,398 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 7,591 | 7,738 | 8,200 | 8,613 | 8,970 |
| Total Liabilities & Shareholders' Equity | 14,005 | 15,105 | 16,483 | 18,080 | 20,368 |
| Total Common Shares Outstanding |